An association of CYP2A6 genotype and smoking topography

Nicotine and Tobacco Research

Volumn 9, Issue 4, 2007, Pages 511-518

  Strasser, Andrew A ^a   Malaiyandi, Viba ^b   Hoffmann, Ewa ^b   Tyndale, Rachel F ^b   Lerman, Caryn ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CYTOCHROME P450 2A6; NICOTINE; NICOTINE PATCH; NITROSAMINE; NOSE SPRAY;

ADULT; ARTICLE; CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COVARIANCE; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK REDUCTION; SEX DIFFERENCE; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; TOPOGRAPHY;

ADULT; ARYL HYDROCARBON HYDROXYLASES; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIXED FUNCTION OXYGENASES; NICOTINE; POLYMERASE CHAIN REACTION; SMOKING; STATISTICS, NONPARAMETRIC; TOBACCO USE DISORDER; VARIATION (GENETICS);

EID: 34047215092     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1080/14622200701239605     Document Type: Article

References (40)

1. Ahijevych, K. and Gillespie, J. (1997) Nicotine dependence and smoking topography among Black and White women. Research in Nursing and Health, 20, pp. 505-514.
2. Ariyoshi, N., Miyamoto, M., Umetsu, Y., Kunitoh, H., Dosaka-Akita, H., Sawamura, Y., Yokota, J., Nemoto, N., Sato, K. and Kamataki, T. (2002) Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers. Cancer Epidemiology, Biomarkers, &Prevention, 11, pp. 890-894.
3. Benowitz, N., Hall, S., Herning, R., Jacob, P., Jones, R. and Osman, A. (1983) Smokers of low-yield cigarettes do not consume less nicotine. The New England Journal of Medicine, 309, pp. 139-142.
4. Benowitz, N., Tyndale, R. F., Jacob, P. I. and Swan, G. E. (2002) CYP2A6 polymorphisms and nicotine metabolism. Clinical Pharmacology and Therapeutics, 71, p. 41.
5. Burling, A. S. and Burling, T. A. (2003) A comparison of self-report measures of nicotine dependence among male drug/alcohol-dependent cigarette smokers. Nicotine & Tobacco Research, 5, pp. 625-633.
6. Carmelli, D., Swan, G. E., Robinette, D. and Fabsitz, R. (1992) Genetic influence on smoking - A study of male twins. The New England Journal of Medicine, 327, pp. 829-833.
7. Djordjevic, M. V., Stellman, S. D. and Zang, E. (2000) Doses of nicotine and lung carcinogens delivered to cigarette smokers. Journal of the National Cancer Institute, 92, pp. 106-111.
8. Eissenberg, T., Adams, C., Riggins, 3rd. and Likness, M. (1999) Smokers' sex and the effects of tobacco cigarettes: Subject-rated and physiological measures. Nicotine & Tobacco Research, 1, pp. 317-324.
9. Fujieda, M., Yamazaki, H., Saito, T., Kiyotani, K., Gyamfi, M. A., Sakurai, M., Dosaka-Akita, H., Sawamura, Y., Yokota, J., Kunitoh, H. and Kamataki, T. (2004) Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers. Carcinogenesis, 25, pp. 2451-2458.
10. Fukami, T., Nakajima, M., Yoshida, R., Tsuchiya, Y., Fujiki, Y., Katoh, M., McLeod, H. L. and Yokoi, T. (2004) A novel polymorphism of human CYP2A6 gene CYP2A6*17 has an amino acid substitution (V365M) that decreases enzymatic activity in vitro and in vivo. Clinical Pharmacology and Therapeutics, 76, pp. 519-527.
11. Goodz, S. D. and Tyndale, R. F. (2002) Genotyping human CYP2A6 variants. Methods in Enzymology, 357, pp. 59-69.
12. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C. and Fagerstróm, K. O. (1991) The Fagerstróm Test for Nicotine Dependence: A revision of the Fagerstróm Tolerance Questionnaire. British Journal of Addiction, 86, pp. 1119-1127.
13. Hecht, S. S. and Hoffman, D. (1988) Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis, 9, pp. 875-884.
14. Hecht, S. S., Murphy, S. E., Carmella, S. G., Li, S., Jensen, J., Le, C., Joseph, A. M. and Hatsukami, D. K. (2005) Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettes. Cancer Epidemiology, Biomarkers, and Prevention, 14, pp. 693-698.
15. Hoffman, S. M., Fernandez-Salguero, P., Gonzalez, F. J. and Mohrenweiser, H. W. (1995) Organization and evolution of the cytochrome P450 CYP2A-2B-2F subfamily gene cluster on human chromosome 19. Journal of Molecular Evolution, 41, pp. 894-900.
16. Kharasch, E. D., Hankins, D. C. and Taraday, J. K. (2000) Single-dose methoxsalen effects on human cytochrome P-450 2A6 activity. Drug Metabolism and Disposition, 28, pp. 28-33.
17. Koenigs, L. L., Peter, R. M., Thompson, S. J., Rettie, A. E. and Trager, W. F. (1997) Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen. Drug Metabolism and Disposition, 25, pp. 1407-1415.
18. Lerman, C. and Berrettini, W. (2003) Elucidating the role of genetic factors in smoking behavior and nicotine dependence. American Journal of Medical Genetics, 118, pp. 48-54.
19. Lerman, C., Kaufmann, V., Rukstalis, M., Patterson, F., Perkins, K., Audrain-McGovern, J. and Benowitz, N. (2004) Individualizing nicotine replacement therapy for the treatment of tobacco dependence: A randomized trial. Annals of Internal Medicine, 140, pp. 426-433.
20. London, S., Idle, J., Daly, A. and Coetzee, G. (1999) Genetic variation of CYP2A6, smoking, and risk of cancer. Lancet, 353, pp. 898-899.
21. Madden, P., Heath, A., Pedersen, N., Kaprio, J., Koskenvuo, M. and Martin, N. (1999) The genetics of smoking persistence in men and women: A multicultural study. Behavior Genetics, 29, pp. 423-431.
22. Malaiyandi, V., Sellers, E. M. and Tyndale, R. F. (2005) Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence. Clinical Pharmacology and Therapeutics, 77, pp. 145-158.
23. Messina, E. S., Tyndale, R. F. and Sellers, E. M. (1997) A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. Journal of Pharmacology and Experimental Therapeutics, 282, pp. 1608-1614.
24. Miyamoto, M., Umetsu, Y., Dosaka-Akita, H., Sawamura, Y., Yokota, J., Kunitoh, H., Nemoto, N., Sato, K., Ariyoshi, N. and Kamataki, T. (1999) CYP2A6 gene deletion reduces susceptibility to lung cancer. Biochemical and Biophysical Research Communications, 261, pp. 658-660.
25. Munafó, M. R., Shields, A. E., Berrettini, W. H., Patterson, F. and Lerman, C. (2005) Pharmacogenetics and nicotine addiction treatment. Pharmacogenomics, 6, pp. 211-223.
26. Nakajima, M., Kwon, J. T., Tanaka, N., Zenta, T., Yamamoto, Y., Yamamoto, H., Yamakazi, H., Yamamoto, T., Kuroiwa, Y. and Yokoi, T. (2001) Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans. Clinical Pharmacology and Therapeutics, 69, pp. 72-78.
27. O'Loughlin, J., Paradis, G., Kim, W., DiFranza, J., Meshefedjian, G., McMillan-Davey, E., Wong, S., Hanley, J. and Tyndale, R. F. (2004) Genetically decreased CYP2A6 and the risk of tobacco dependence: A prospective study of novice smokers. Tobacco Control, 13, pp. 422-428.
28. Rao, Y., Hoffmann, E., Zia, M., Bodin, L., Zeman, M., Sellers, E. M. and Tyndale, R. F. (2000) Duplications and defects in the CYP2A6 gene: Identification, genotyping, and in vivo effects on smoking. Molecular Pharmacology, 58, pp. 747-755.
29. Schoedel, K. A., Hoffmann, E. B., Rao, Y., Sellers, E. M. and Tyndale, R. F. (2004) Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians. Pharmacogenetics, 14, pp. 615-626.
30. Sellers, E. M., Ramamoorthy, Y., Zeman, M. V., Djordjevic, M. V. and Tyndale, R. F. (2003) The effect of methoxsalen on nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism in vivo. Nicotine & Tobacco Research, 5, pp. 891-899.
31. Sellers, E. M., Tyndale, R. F. and Fernandes, L. C. (2003) Decreasing smoking behaviour and risk through CYP2A6 inhibition. Drug Discovery Today, 8, pp. 487-493.
32. Smith, C. J., Perfetti, T. A., Garg, R. and Hansch, C. (2003) IARC carcinogens reported in cigarette mainstream smoke and their calculated log P values. Food and Chemical Toxicology, 41, pp. 807-817.
33. Strasser, A. A., Ashare, R. L., Kozlowski, L. T. and Pickworth, W. B. (2005) The effect of filter vent blocking and smoking topography on carbon monoxide levels in smokers. Pharmacology, Biochemistry, and Behavior, 82, pp. 320-329.
34. Sullivan, P. F. and Kendler, K. S. (1999) The genetic epidemiology of smoking. Nicotine & Tobacco Research, 1, pp. S51-S57; discussion S69-S70.
35. Takeuchi, H., Saoo, K., Matsuda, Y., Yokohira, M., Yamakawa, K. and Zeng, Y. (2006) Dose dependent inhibitory effects of dietary 8-methoxypsoralen on NNK-induced lung tumorigenesis in femal A/J mice. Cancer Letters, 234, pp. 232-238.
36. True, W. R., Heath, A. C., Scherrer, J. F., Waterman, B., Goldberg, J., Lin, N., Eisen, S. A., Lyons, M. J. and Tsuang, M. T. (1997) Genetic and environmental contributions to smoking. Addiction, 92, pp. 1277-1287.
37. U.S. Department of Health and Human Services Tobacco use among U.S. racial/ethnic minority groups - African Americans, American Indians and Alaska Natives, Asian Americans and Pacific Islanders, and Hispanics. A report of the surgeon general
38. Xian, H., Scherrer, J. F., Madden, P. A., Lyons, M. J., Tsuang, M., True, W. R. and Eissen, S. A. (2003) The heritability of failed smoking cessation and nicotine withdrawal in twins who smoked and attempted to quit. Nicotine & Tobacco Research, 5, pp. 245-254.
39. Xu, C., Rao, Y. S., Xu, B., Hoffmann, E., Jones, J., Sellers, E. M. and Tyndale, R. F. (2002) An in vivo pilot study characterizing the new CYP2A6*7, *8, and *10 alleles. Biochemical and Biophysical Research Communications, 290, pp. 318-324.
40. Zacny, J. P., Stitzer, M. L., Brown, F. J., Yingling, J. E. and Griffiths, R. R. (1987) Human cigarette smoking: Effects of puff and inhalation parameters on smoke exposure. Journal of Pharmacology and Experimental Therapeutics, 240, pp. 554-564.